Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dabin Ren, Peter Bajorski, Timothy F. Murphy, Eric R. Lafontaine & Michael E. Pichichero. (2020) Synchrony in serum antibody response to conserved proteins of Moraxella catarrhalis in young children. Human Vaccines & Immunotherapeutics 16:12, pages 3194-3200.
Read now
Read now
Michael E. Pichichero. (2017) Pneumococcal whole-cell and protein-based vaccines: changing the paradigm. Expert Review of Vaccines 16:12, pages 1181-1190.
Read now
Read now
Anthony Almudevar & Michael E. Pichichero. (2017) Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial. Human Vaccines & Immunotherapeutics 13:10, pages 2316-2321.
Read now
Read now
Michael E Pichichero, M Nadeem Khan & Qingfu Xu. (2016) Next generation protein based Streptococcus pneumoniae vaccines. Human Vaccines & Immunotherapeutics 12:1, pages 194-205.
Read now
Read now
Articles from other publishers (8)
I. M. Gruber, O. M. Kukina, N. B Egorova, & O. V. Zhigunova. (2021) Different Technologies for Obtaining Pneumococcal Immunogens. Epidemiology and Vaccinal Prevention 20:1, pages 76-91.
Crossref
Crossref
Hannah M. Rowe, Beth Mann, Amy Iverson, Aaron Poole, Elaine Tuomanen & Jason W. Rosch. (2019) A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media. Infection and Immunity 87:10.
Crossref
Crossref
Dabin Ren, Anthony L. Almudevar, Timothy F. Murphy, Eric R. Lafontaine, Anthony A. Campagnari, Nicole Luke-Marshall & Michael E. Pichichero. (2019) Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children. Vaccine 37:32, pages 4637-4645.
Crossref
Crossref
Theano Lagousi, Paraskevi Basdeki, John Routsias & Vana Spoulou. (2019) Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens. Vaccines 7:1, pages 9.
Crossref
Crossref
Melinda M. Pettigrew, Mark R. Alderson, Lauren O. Bakaletz, Stephen J. Barenkamp, Anders P. Hakansson, Kevin M. Mason, Johanna Nokso‐Koivisto, Janak Patel, Stephen I. Pelton & Timothy F. Murphy. (2017) Panel 6: Vaccines. Otolaryngology–Head and Neck Surgery 156:S4.
Crossref
Crossref
Ruth B. Thornton, Lea-Ann S. Kirkham, Karli J. Corscadden, Harvey L. Coates, Shyan Vijayasekaran, Jessica Hillwood, Sophie Toster, Phillipa Edminston, Guicheng Zhang, Anthony Keil & Peter C. Richmond. (2017) No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media. International Journal of Pediatric Otorhinolaryngology 92, pages 119-125.
Crossref
Crossref
Gyu-Lee Kim, Sang-Yoon Choi, Seung-Han Seon, Seungyeop Lee, Sang-Sang Park, Joon Young Song, David E. Briles & Dong-Kwon Rhee. (2016) Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains. Vaccine 34:51, pages 6481-6492.
Crossref
Crossref
Igor C. Borges, Dafne C. Andrade, Maria Regina A. Cardoso, Jorma Toppari, Mari Vähä-Mäkilä, Jorma Ilonen, Mikael Knip, Heikki Hyöty, Riitta Veijola, Olli Simell, Tuomas Jartti, Helena Käyhty, Olli Ruuskanen & Cristiana M. Nascimento-Carvalho. (2016) Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clinical and Vaccine Immunology 23:11, pages 878-883.
Crossref
Crossref